Blood and Marrow Transplant Clinical Research Network

Summary

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

Conditions

• Bone Marrow Transplantation
• Blood Disease
• Hematopoietic Stem Cell Transplantation
• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Graft vs Host Disease

Interventions

DRUG

fluconazole

DRUG

voriconazole

PROCEDURE

bone marrow transplant

DRUG

thalidomide

DRUG

dexamethasone

Sponsors & Collaborators

• Blood and Marrow Transplant Clinical Trials Network

  collaborator NETWORK

• National Heart, Lung, and Blood Institute (NHLBI)

  lead NIH

Principal Investigators

• Joseph Antin · Dana-Farber Cancer Institute

• Frederick Appelbaum · Fred Hutchinson Cancer Center

• Edward Ball · University of California, San Diego

• James Ferrara · University of Michigan at Ann Arbor

• Stephen Forman · City of Hope National Medical Center

• Alan Gamis · Children's Mercy Hospital Kansas City

• Sergio Giralt · M.D. Anderson Cancer Center

• Mary Horowitz · Medical College of Wisconsin

• Richard Jones · Johns Hopkins University

• Joanne Kurtzberg · Duke University

• Gina Laport · Stanford University

• Hillard Lazarus · Case Western Reserve University

• Richard O'Reilly · Sloan-Kettering Institute for Cancer Research

• Edward Stadtmauer · University of Pennsylvania

• Julie Vose · University of Nebraska

• Daniel Weisdorf · University of Minnesota

• John Wingard · University of Florida

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Eligibility

Min Age

2 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2001-09-30

Completion

2006-08-31

Countries

• United States

Study Locations